top of page
Peptide therapies
Six Peptides Just Cleared an FDA Advisory Vote. Here Is What That Does and Does Not Mean
On July 23 and 24, 2026, the FDA's Pharmacy Compounding Advisory Committee met at the agency's White Oak campus to review seven peptides for possible inclusion on the Section 503A Bulk Drug Substances List.
The committee recommended six of the seven: BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax. A seventh, emideltide (also called delta sleep-inducing peptide, or DSIP), was voted down.
JoBeth Augustyniak, DO
4 days ago6 min read
When GLP-1 Medications Cause Skin Pain: A Side Effect Worth Knowing About
A real patient encounter that led me down a research rabbit hole — and what I found. By Dr. JoBeth Augustyniak, DO, AOBFP | Attune Direct Care & Wellness | Metabolic Health Intricate visualization of the human nervous system, highlighting the complexity and intensity of nerve pathways where severe nerve pain can manifest. Recently, I had a patient who made the decision to restart her GLP-1 medication after regaining weight following a period off it. She is otherwise healt
JoBeth Augustyniak, DO
Jun 166 min read
Understanding Peptide Therapy: Legalities, Doctor-Patient Decisions, and Key Considerations
Peptide therapy has gained attention for its potential to support healing, improve metabolism, and enhance overall wellness.
JoBeth Augustyniak, DO
Apr 274 min read
bottom of page